BPG is committed to discovery and dissemination of knowledge
Basic Study
©The Author(s) 2015.
World J Gastroenterol. Jan 7, 2015; 21(1): 155-163
Published online Jan 7, 2015. doi: 10.3748/wjg.v21.i1.155
Figure 3
Figure 3 Vasoactive intestinal peptide in plasma after trinitrobenzene sulfonic acid treatment. Plasma concentration of vasoactive intestinal peptide (VIP) was assessed in naïve animals and after trinitrobenzene sulfonic acid (TNBS) treatment at the 2-h and 14-d time-points using a peptide enzyme immunoassay. n = 4 for all conditions, aP < 0.05 vs controls; ANOVA with Dunnett’s posttests.


Write to the Help Desk